secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K/A
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001493152-23-008217
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience acquires Wisconsin Fertility Institute for $10M; clinic had $5.7M revenue in 2021
--------------------------------------------------------------------------------

- Total purchase price $10M, payable in four annual $2.5M installments.
- Sellers can elect to receive INVO common stock at $6.25, $9.09, $14.29 for installments 2-4.
- Clinic revenue $5.7M (2021), $4.5M (2020); net income $2.3M and $1.3M respectively.
- Acquisition includes WFRSA medical practice and FLOW lab services; expected close Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/0001493152-23-008217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer